Document is current
Any future updates will be listed below
-
Authors
Zhang, Naixin
Wilson, Ben
Enty, Morgan A.
Ketch, Peter
Ulm, Michael A.
ElNaggar, Adam C.
Daily, Laura
Tillmanns, Todd https://orcid.org/0000-0002-1520-1089
- License Information
-
More Information
Article History
Received: 24 February 2021
Accepted: 8 May 2021
First Online: 8 July 2021
Declarations
:
: Dr. ElNaggar reports non-financial support from Caris Life Sciences, AstraZeneca, and Tesaro/GSK, as well as consulting fees from AstraZeneca, AbbVie, Merck, Leap Therapeutics, and Clovis Oncology during the conduct of the study. Dr. Tillmanns receives personal fees from AztraZeneca and Johnson and Johnson. No disclosures from other authors. All fees are outside of submitted work.
: This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of University B approved this study.
: Informed consent was waived after discussion with the University of Tennessee Health Sciences center given the retrospective nature of this study.
